-
1
-
-
0023584098
-
The commonest glomerulonephritis in the world: IgA nephropathy
-
D'Amico G. The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 64 (1987) 709-727
-
(1987)
Q J Med
, vol.64
, pp. 709-727
-
-
D'Amico, G.1
-
2
-
-
0026043321
-
Deterioration of GFR in IgA nephropathy as measured by 51Cr-EDTA clearance
-
Rekola S., Bergstrand A., and Bucht H. Deterioration of GFR in IgA nephropathy as measured by 51Cr-EDTA clearance. Kidney Int 49 (1991) 1050-1054
-
(1991)
Kidney Int
, vol.49
, pp. 1050-1054
-
-
Rekola, S.1
Bergstrand, A.2
Bucht, H.3
-
4
-
-
0028955139
-
Immunomodulation with low-dose immunoglobulins for moderate IgA nephropathy and Henoch-Schonlein purpura. Preliminary results of a prospective uncontrolled trial
-
Rostoker G., Desvaux-Belghiti D., Pilatte Y., et al. Immunomodulation with low-dose immunoglobulins for moderate IgA nephropathy and Henoch-Schonlein purpura. Preliminary results of a prospective uncontrolled trial. Nephron 69 (1995) 327-334
-
(1995)
Nephron
, vol.69
, pp. 327-334
-
-
Rostoker, G.1
Desvaux-Belghiti, D.2
Pilatte, Y.3
-
6
-
-
34249043594
-
A novel simpler histological classification for renal serviva in IgA nephropathy: a retrospective study
-
Manno C., Strippoli G.F., D'Altri C., et al. A novel simpler histological classification for renal serviva in IgA nephropathy: a retrospective study. Am J Kidney Dis 49 (2007) 763-775
-
(2007)
Am J Kidney Dis
, vol.49
, pp. 763-775
-
-
Manno, C.1
Strippoli, G.F.2
D'Altri, C.3
-
7
-
-
57749193517
-
Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial
-
Lv J., Zhang H., Chen Y., et al. Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial. Am J Kidney Dis 53 (2009) 26-32
-
(2009)
Am J Kidney Dis
, vol.53
, pp. 26-32
-
-
Lv, J.1
Zhang, H.2
Chen, Y.3
-
9
-
-
0942287104
-
The number, quality and coverage of randomized controlled trials in nephrology
-
Strippoli G.F., Craig J.C., and Schena F.P. The number, quality and coverage of randomized controlled trials in nephrology. J Am Soc Nephrol 15 (2004) 411-419
-
(2004)
J Am Soc Nephrol
, vol.15
, pp. 411-419
-
-
Strippoli, G.F.1
Craig, J.C.2
Schena, F.P.3
-
10
-
-
0038777450
-
An 'evidence-based' survey of therapeutic options for IgA nephropathy: assessment and criticism
-
Strippoli G.F.M., Manno C., and Schena F.P. An 'evidence-based' survey of therapeutic options for IgA nephropathy: assessment and criticism. Am J Kidney Dis 41 (2003) 1129-1139
-
(2003)
Am J Kidney Dis
, vol.41
, pp. 1129-1139
-
-
Strippoli, G.F.M.1
Manno, C.2
Schena, F.P.3
-
11
-
-
29444443206
-
A road map for efficient and reliable human genome epidemiology
-
Ioannidis J.P., Gwinn M., Little J., et al. A road map for efficient and reliable human genome epidemiology. Nat Genet 38 (2008) 3-5
-
(2008)
Nat Genet
, vol.38
, pp. 3-5
-
-
Ioannidis, J.P.1
Gwinn, M.2
Little, J.3
-
12
-
-
0030604561
-
Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy
-
The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)
-
The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 349 (1997) 1857-1863
-
(1997)
Lancet
, vol.349
, pp. 1857-1863
-
-
-
13
-
-
0032541831
-
Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial
-
Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN)
-
Ruggenenti P., Perna A., Gherardi G., et al., Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Lancet 352 (1998) 1252-1256
-
(1998)
Lancet
, vol.352
, pp. 1252-1256
-
-
Ruggenenti, P.1
Perna, A.2
Gherardi, G.3
-
14
-
-
44949205473
-
Stopping a trial early in oncology: for patients or for industry?
-
Trotta F., Apolone G., Garattini S., et al. Stopping a trial early in oncology: for patients or for industry?. Ann Oncol 19 (2008) 1347-1353
-
(2008)
Ann Oncol
, vol.19
, pp. 1347-1353
-
-
Trotta, F.1
Apolone, G.2
Garattini, S.3
-
15
-
-
27144461980
-
Hypothesis versus association: the optimal hemoglobin target debate
-
Strippoli G.F., and Craig J.C. Hypothesis versus association: the optimal hemoglobin target debate. Am J Kidney Dis 46 (2005) 970-973
-
(2005)
Am J Kidney Dis
, vol.46
, pp. 970-973
-
-
Strippoli, G.F.1
Craig, J.C.2
-
16
-
-
42049107348
-
Telmisartan, ramilpril, or both in patients at high risk for vascular events
-
ONTARGET Investigators
-
ONTARGET Investigators. Telmisartan, ramilpril, or both in patients at high risk for vascular events. N Engl J Med 358 (2008) 1547-1559
-
(2008)
N Engl J Med
, vol.358
, pp. 1547-1559
-
-
-
17
-
-
57749185752
-
-
NAPRTCS (North American Pediatric Renal Trials and Collaborative Studies) Accessed Sept 15, 2008
-
NAPRTCS (North American Pediatric Renal Trials and Collaborative Studies). http://spitfire.emmes.com/study/ped/index.htm Accessed Sept 15, 2008
-
-
-
|